Eleanor Health, a Waltham, MA-based addiction and mental health provider delivering comprehensive, whole-person care through population- and value-based payment models, closed a $50M Series C financing.
The round was led by General Catalyst with participation from existing investors including Warburg Pincus and Town Hall Ventures, as well as new participation from Northpond Ventures and Rethink Impact.
The company intends to use the funds to foster new risk-based, population health partnerships, expand into new markets, including Texas, and continue building its proprietary care delivery and analytics platform to scale its evidence-based, data-driven, whole-person care model in communities across its six current markets.
Led by founders, Corbin Petro and Nzinga Harrison, who launched the company in 2019, Eleanor Health provides evidence-based, whole-person care specializing in addressing the unique complexities of individuals and populations with substance use disorders and mental health needs. The company leverages proprietary technology and data-driven insights, compassionate teams, and population- and value-based payment to deliver clinical and financial outcomes.
To date, Eleanor has launched local partnerships with Tufts, Amerigroup, Optum and a national partnership with Aetna’s commercial business. By the end of 2022, the company will manage more than 60,000 members.
FinSMEs
07/04/2022